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Background: The incidence of geriatric oncology patients has not been studied very well. A retrospective
study of the incidence of geriatric patients with malignant gynecological disease is therefore presented.
Patients and methods: From 1982 until 2006, a total of 8377 patients with gynecological malignancies
were treated in our clinic, 834 (10%) of whomwere aged 70 years. In the analysis, annual reports of the
clinic were used and the personal histories of patients aged 70 years (834 patients) were analyzed. The
statistical method used was Fisher's exact test.
Results: The number of patients aged 70e74 years, 75e79 years, and 80 years were 528 (63.3%), 215
(25.8%), and 91 (10.9%), respectively. Endometrial cancer was detected in 240 cases (28.77%), ovarian
cancer in 192 cases (23.02%), vulvar cancer in 180 cases (21.58%), cervical cancer in 169 cases (20.26%),
uterine sarcoma in 37 cases (4.43%), and vaginal cancer in 16 cases (1.91%). The comorbidities included
were hypertension, diabetes, cardiovascular disease, pulmonary disease, and cerebrovascular disease.
Operation was performed in 655 cases (78%), radiation therapy only in 152 cases (18%), and chemo-
therapy only in 27 cases (3%). In the present study, the in-hospital complication rate occurred in 78 cases
(9.3%). In the group of patients aged >80 years, the in-hospital complication rate occurred in 20 cases
(21%). No case of death related to surgery occurred.
Conclusion: The key in choosing the treatment therapy is the localization and the stage of the cancer,
whereas patient age and different chronic diseases are relevant to the treatment strategies used. The
cases of geriatric gynecological malignancies were treated following the same guidelines used for
younger patients. An increase in elderly surgical cancer workload is inevitable in the coming years. The
special needs of elderly cancer patients should be taken into consideration prior to treatment planning.
Copyright © 2015, Taiwan Society of Geriatric Emergency & Critical Care Medicine. Published by Elsevier
Taiwan LLC. All rights reserved.1. Introduction
The deﬁnition of “elderly” is controversial. Functional deterio-
ration is more frequently apparent beyond the age of 70 years1. No
two elderly individuals are the same: they differ in their physical
ﬁtness, cognitive level, presence of comorbidities, quality of life,
and life expectations. Surprisingly, few objective instruments have
been made available to categorize age-related preexisting chronic
illness, age-related functional physical decline, or preoperative risk
status1e3. At the end of the 19th century, the average life expectancyre that they have no conﬂicts
al Oncology, National Onco-
lgaria.
tric Emergency & Critical Care Mewas 40 years, but it has now doubled to 81 years of expected sur-
vival for females and 76 years for males in the United Kingdom. A
60-year-old individual is now expected to survive for 24 years and
an 80-year-old is expected to survive for 6 years in Western
Europe4. By contrast, the risk of developing cancer increases with
age. According to the Cancer Incidence, Mortality and Prevalence in
the European Union 90 data, 58% of cancers, and 69% of cancer
deaths, affect individuals aged 65 years or more. Advanced age is
associated with a signiﬁcant number of malignant diseases. Despite
the increased interest in treatment of senior cancer patients, older
patients aremuch too often undertreated5. The incidence of ovarian
carcinoma increases with advancing age, peaking during the 7th
decade of life and remaining elevated until the age of 80 years6.
Advanced age is associated with a signiﬁcantly worse prognosis for
endometrial carcinoma patients. It appears that with advancing
age, endometrial carcinoma exhibits a more aggressive tumordicine. Published by Elsevier Taiwan LLC. All rights reserved.
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regulation of E-cadherin expression, and this, in turn, results in
tumors being diagnosed at a more advanced stage in older pa-
tients7. Studies have demonstrated that age is a risk factor that af-
fects surgical outcome, and surgery is infrequently offered to older
cancer patients because of the increased risk of surgical morbidity
and mortality8. Thus, the decision to perform surgery on older
patients often presents as an ethical dilemma9. During the past
decade, oncologists and geriatricians have begun to work together
to integrate the principles of geriatrics into oncology care. The
increasing use of a comprehensive geriatric assessment (CGA) is
one example of this effort. A CGA includes an evaluation of an older
individual's functional status, comorbid medical conditions,
cognition, nutritional status, psychological state, and social sup-
port, as well as a review of the patient's medications. Growing
evidence demonstrates that the variables examined in a CGA can
predict morbidity and mortality in older patients with cancer, and
uncover problems relevant to cancer care that would otherwise go
unrecognized10. A number of studies have demonstrated that in
highly functional elderly patients without comorbidities, post-
operative clinical outcomes are similar to those of younger pa-
tients11,12; however, other research has shown that older cancer
patients probably receive less curative treatment compared with
younger patients13.
The aim of this study is to determine the impact of comorbid-
ities on surgical complications and the mortality of older gyneco-
logical cancer patients, with the hope of providing more
information on surgical risk that could be used to evaluate patients
with different chronic diseases, especially in cases of patients aged
>80 years.
2. Patients and methods
From 1982 until 2006 in our clinic (Department of Gynecological
Oncology at the National Oncology Center, Soﬁa, Bulgaria), a total of
8377 patients with gynecological malignancies according to the
International Statistical ClassiﬁcationofDiseases andRelatedHealth
Problems, 10th Revision (ICD-10)14 (C51eC56) and 1198 patients
with carcinoma in situ (D06) were treated. Overall, 834 (10%) of all
patientswith gynecologicalmalignancieswere aged 70 years. The
comorbidities included in the present study were hypertension,
diabetes, cardiovascular disease, pulmonary disease, and cerebro-
vascular disease. The principal and secondary diagnoses in preop-
erative claims data were used to determine whether a patient had
anyof these diseases prior to surgery. The diagnosis of a comorbidity
was deﬁned according to the ICD-1014, code for hypertension
(I10eI15), cardiovascular disease (I20eI 25, I26eI28, I30eI52), ce-
rebrovascular disease (I60eI69), venous disease (I80eI89), pulmo-
nary disease (J40eJ47), and diabetes (E10eE14). All patients were
submitted to theCancer Committee of theNationalOncologyCenter,
where therapeutic tactics were chosen, according to medical stan-
dards and ethical standards and procedures for research with hu-
man beings. All patients signed informed consent to participate in
the proposed treatment. The study is retrospective and was
approved by the ethical committee of the National Oncology Center,
Soﬁa, Bulgaria. Preoperatively, all patients were assessed by an
anesthesiologist to determine their physical status and operative
risk using the American Society of Anesthesiologists (ASA) scoring
system15. In some cases, the operationwas contraindicated because
of cardiovascular, pulmonary, or cerebral diseases.
2.1. Statistical method
Fisher's exact test was used for calculating the statistical
signiﬁcance.The test was used to determine whether the outcome of a study
would lead to a rejection of the null hypothesis based on a pre-
speciﬁed low probability threshold called p values, which can help
an investigator decide if a result contains sufﬁcient information to
cast doubt on the null hypothesis. The p values are often coupled to
a signiﬁcance or alpha (a) level, which is also set ahead of time,
usually at 0.05 (5%), such as 0.1 or 0.0001. Thus, if a p value was
found to be less, the null hypothesis would be rejected16.
3. Results
Of the 834 patients, 528 patients (63.3%) were aged 70e74 years,
215 patients (25.8%) were aged 75e79 years, and 91 patients
(10.9%) were aged  80 years. The highest number of patients
consisted of individuals with endometrial cancerd240 cases.
Ovarian cancer was detected in 192 cases and vulvar cancer in 180
cases. Cervical cancer was diagnosed in 169 cases, uterine sarcoma
in 37 cases, and vaginal cancer in 16 cases (Table 1). Operation and
radiation were used in cases of endometrial, cervical, and vulvar
cancers. In 144 cases of endometrial cancer, total abdominal hys-
terectomy with bilateral salpingo-oophorectomy was performed,
and in 26 cases radical abdominal hysterectomies with lymph node
dissections with postoperative radiation were performed. In 70
patients with endometrial cancer, radiation therapy alone was
used. In 115 patients with cervical cancer, radical abdominal hys-
terectomies with lymph node dissections and postoperative radi-
ation were performed. The rest (54 patients with cervical cancer)
were treated with radiation therapy only. In 123 cases of vulvar
cancer, vulvectomy with lymph node dissections was conducted,
and in 45 cases a vulvectomy only and postoperative radiationwere
performed. In 12 cases of vulvar cancer, radiation therapy only was
used. The patients with vaginal cancer were treated with radiation
therapy only. In cases of ovarian cancer, operation and chemo-
therapy were performed. In 102 cases of ovarian cancer, total
abdominal hysterectomy with bilateral salpingo-oophorectomies
and omentectomy with postoperative chemotherapy were per-
formed. In 65 cases of ovarian cancer postoperative chemotherapy
were performed. Twenty-ﬁve patients with ovarian cancer were
treated with chemotherapy only. In 35 cases of uterine sarcoma,
total abdominal hysterectomy with bilateral salpingo-
oophorectomies with postoperative radiation was performed. In
two cases of uterine sarcoma, chemotherapy only was used.
In the present study, the in-hospital complication rate for all 834
patients was 9.3%. In the group of patients aged >80 years, the in-
hospital complication rate was 21%. Table 1 shows the patient
characteristics and in-hospital complication rate. Thus, for the age
group 70e74 years there are 528 patients, comprising 63% of all
cases (834). In 27 patients aged 70e74 years, which represents 5%
of all patients in this age group (528 cases), in-hospital complica-
tion was present.
The ASA physical status classiﬁcation was as follows: 425/834
(51%) class II, 230/834 (28%) class III, and 179/834 (21%) class IV.
Operationwas performed in 655/834 cases (78%), radiation therapy
only in 152/834 cases (18%), and chemotherapy only in 27/834
cases (3%; Table 2). Breakdown of the procedures performed shows
281 total abdominal hysterectomy with bilateral salpingo-
oophorectomies (in 102 cases with omentectomy), 141 radical
abdominal hysterectomies with lymph node dissections, 65 tumor
reduced surgery (bilateral salpingo-oophorectomies with omen-
tectomy), 123 vulvectomy with lymph node dissections, and 45
vulvectomy only. In our series, the complication rate was only 9.3%,
and there was no death in the postoperative period. Table 3 shows
the in-hospital complications in relation to comorbidities. Signiﬁ-
cant trends were found at the level of p < 0.05, which is consistent
with the methods description16.
Table 1





rateb (N ¼ 78)
Age (y)
70e74 528 (63) 27 (5)
75e79 215 (26) 31 (14)
80 91 (11) 20 (21)
Cancer type by anatomical site
Cervical cancer 169 (20) 14 (8)
Endometrial cancer 240 (29) 10 (2)
Ovary cancer 192 (23) 40 (20)
Vulvar cancer 180 (22) 10 (2)
Vagina cancer 16 (2) 2 (12)
Uterine sarcоma 37 (4) 2 (5)
Tumor stage
Stage I 410 (49) 31 (7)
Stages IIeIII 393 (47) 42 (11)
Stage IVc 31 (4) 5 (16)
Operation mode
Total abdominal hysterectomy 281 (43) 11 (4)
Radical abdominal hysterectomy
and lymph node dissection
141 (21) 23 (16)
Tumor reduced surgery 65 (10) 20 (30)
Vulvectomy 45 (7) 1 (2)
Vulvectomy and lymph node dissection 123 (19) 4 (3)
Chemotherapy only
No 807 (97)
Yes 27 (3) 7 (26)
Radiation therapy only
No 682 (82)
Yes 152 (18) 12 (8)
Hypertension
No 174 (21)
Yes 660 (79) 22 (3)
Cardiovascular disease
No 189 (23)
Yes 645 (77) 31 (5)
Cerebrovascular disease
No 630 (76)
Yes 204 (24) 10 (5)
Pulmonary disease
No 581 (61)
Yes 253 (39) 5 (2)
Diabetes
No 473 (57)
Yes 361 (43) 10 (3)
Data are presented as n (%).
a The calculation of “percentage, %” after each number in the ﬁrst column (study
population) was based on the total number of patientsd834 cases. In the second
column (in-hospital complication rate), the calculation of “percentage, %”was based
on the number of patients with complications in the according group of the study
population.
b In-hospital complication related with surgery, chemotherapy, and radiation.
c Four patients with Stage IV were treated with radiation only and 27 patients
with Stage IV were treated with chemotherapy only.
Table 2
Characteristics of the stage and treatment.
Diagnosis Stage
I II III IV
Cervical cancer 115 (68) 10 (6) 42 (25) 2 (1)
Endometrial cancer 144 (60) 26 (11) 68 (28) 2 (1)
Ovary cancer 18 (9) 84 (44) 65 (34) 25 (13)
Vulvar cancer 123 (68) 45 (25) 12 (7) d
Vagina cancer d d 16 (100) d
Uterine sarcoma 10 (27) 25 (68) d 2 (1)
Total 401 (48) 190 (23) 203 (17) 31 (3)
Data are presented as n (%).
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After adjusting for other prognostic factors, the presence of ce-
rebrovascular disease, cardiovascular disease, diabetes, or hyper-
tension signiﬁcantly affected the risk of surgical complications
among older patients undergoing surgical treatment for gyneco-
logical cancer (Table 3). In our study, age did not show a signiﬁcant
effect on the rate of in-hospital complications among older gyne-
cological cancer surgical patients if they were aged <80 years;
however, patients aged 80 years accounted for 21% of the com-
plications. It has been established that “age” is a risk factor of early
postsurgical mortality, and that short-term postsurgical mortality
is signiﬁcantly greater in older patients17. Optimal surgical cytor-
eduction had the greatest impact on survival18. Primary surgical
care for ovarian cancer inwomen aged80 years is associated with
utilization of signiﬁcant healthcare resources andworse short-term
outcomes compared with younger women19. Optimal cytoreduc-
tive surgery is feasible in many elderly patients. Women aged
80 years and with poor nutritional status are associated with a
poor survival outcome. Perioperative variables such as these can be
used to identify the elderly patients who are most likely to be
suboptimally cytoreduced and thus have a dismal survival
outcome20. Tumor reduced surgery and chemotherapy only were
used in our series in 10% and 3% of patients, respectively.
Eighty-three percent of patients had one or more preexisting
medical illnesses. Cardiac disease, stroke, and hypertension were
the most common. In patients aged >80 years who undergo
debulking surgery for ovarian cancer, serious medical comorbidity
and advanced ASA status are common. Despite aggressive surgical
efforts and frequent blood transfusions, optimal debulking to
<1 cm is achieved in only 25% of patients. Impressive morbidity and
mortality occurs in this group of patients, however, most patients
are discharged to home and are able to receive postoperative
chemotherapy21. Age at diagnosis has been proven to be an
important determinant of the choice of initial treatment for several
sites of cancer. Elderly patients are more likely to receive no
treatment or less intensive treatment modalities. Although elderly
cervical cancer patients were sometimes treated differently from
younger patients, this was in accordance with the guidelines.
However, when adjustment was made for stage and treatment, this
difference disappeared. The inﬂuence of treatment on survival is
likely to be attributable to the selection of patients based on other
characteristics, such as tumor volume, comorbidity, and perfor-
mance status22. In fact, patients with life expectancies of <5 years
are unlikely to derive any survival beneﬁt from cancer screening23,
and very old patients usually are diagnosed in advanced stages. In
our series, 51% of the patients were in Stage III and Stage IV. The
most important responsibility that a surgeon is asked to take is to
decide whether or not to operate24. This is particularly true when
the patient is considered a high surgical risk25. Currently available
risk assessment tools include the ASA scoring system. The ASATreatment
Total Operation Radiation only Chemotherapy only
169 (100) 115 (68) 54 (32) d
240 (100) 170 (70) 70 (30) d
192 (100) 167 (87) d 25 (13)
180 (100) 168 (93) 12 (7) d
16 (100) d 16 (100) d
37 (100) 35 (95) d 2 (5)
834 (100) 655 (78) 152 (18) 27 (3)
Table 3
In-hospital complications in relation to comorbidities.
Patients Absence of comorbidities Presence of comorbidities p
N In-hospital complication rate N In-hospital complication rate
Hypertension 174 (20.86) 0 660 (79.14) 22 (3.18) <0.0001
Age 70e74 y d 8 (1.21)
Age 75e79 y d 10 (1.51)
Age 80 y d 4 (0.60)
Cardiovascular disease 189 (22.66) 1 (0.52) 645 (77.34) 30 (4.65) <0.0001
Age 70e74 y 1 (0.52) 14 (2.17)
Age 75e79 y d 12 (1.86)
Age 80 y d 4 (0.62)
Cerebrovascular disease 630 (75.54) 0 204 (24.46) 10 (4.90) <0.0001
Age 70e74 y d 2 (0.98)
Age 75e79 y d 3 (1.47)
Age 80 y d 5 (2.45)
Pulmonary disease 581 (69.66) 3 (0.51) 253 (30.34) 2 (0.79) 0.22*
Age 70e74 y d d d
Age 75e79 y 2 (0.34) d d
Age 80 y 1 (0.17) 2 (0.79)
Diabetes 473 (56.71) 0 361 (43.29) 10 (2.77) <0.0001
Age 70e74 y d 3 (0.83)
Age 75e79 y d 5 (1.38)
Age 80 y d 2 (0.55)
Age 174 (20.86) 4 (2.29) 660 (79.14) 74 (11.21) <0.0001
Age 70e74 y 1 (0.57) 27 (4.09) <0.0001
Age 75e79 y 2 (1.15) 30 (4.54) <0.0001
Age 80 y 1 (0.57) 17 (2.57) <0.0001
Data are presented as n (%).
* The result is not signiﬁcant at p > 0.05.
G. Chakalova96scoring system does not measure operative risks; rather, it globally
assesses the degree of sickness or physical state prior to anesthesia
and surgery. The sensitivity of ASA scoring to differentiate the
proportion of patients belonging to ASA class II versus class III26,
where both groups show a similar mortality under elective condi-
tions (15%), is poor.
Optimizing management of cancer in elderly patients requires
better understanding. This can be achieved by encouraging the
elderly to take part in clinical trials speciﬁcally developed for
oncogeriatric series. Elderly cancer patients should be encouraged
to enroll with the same vigor as their younger counterparts. The
recommendations of the consensus meeting held during the 6th
International Conference on Geriatric Oncology27 was that any
elderly cancer patient should ﬁrst be assessed on his/her frailty, and
then considered for appropriate cancer management. The special
needs of elderly cancer patients should be taken into consideration
prior to treatment planning. Developments in surgery and expan-
sion in the elderly cancer knowledge base are the way forward to
optimize cancer surgery for elderly patients28. Neoadjuvant
chemotherapy plus radiotherapy has revealed itself as a potential
application as part of a new therapeutic trend in treating locally
advanced cervical cancer patients29. Older patients with comor-
bidities are at a higher risk of in-hospital complications following
rectal cancer surgery, whereas the presence of comorbidities did
not show a signiﬁcant adverse effect on 1-year mortality30, and a
history of hypertension, diabetes, cardiovascular disease, or cere-
brovascular disease was not a signiﬁcant predictor of 1-year
mortality.
In our series, a higher risk of in-hospital complications was
recorded in patients who were aged >80 years, especially among
ovarian cancer patients treated with tumor reduced surgery or
chemotherapy only and in cases with different chronic diseases.
Healthcare professionals are facing an inevitable increase in the
number of older cancer patients. Whether or not to perform sur-
gery on an older patient should be carefully considered, especially
when surgery remains as the most effective therapy. Our studyindicates that fact, although comorbidities can affect in-hospital
complications. Although we strictly controlled for cancer stage,
presurgical comorbidities, and other prognostic factors, selection
bias still exists, as in previous studies. An increase in elderly surgical
cancer workload is inevitable in the coming years.References
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